ZC3H8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.297400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.783200E-01
Normal-vs-Stage2
4.856400E-01
Normal-vs-Stage3
1.329840E-01
Normal-vs-Stage4
8.694600E-01
Stage1-vs-Stage2
6.042600E-01
Stage1-vs-Stage3
1.434240E-01
Stage1-vs-Stage4
8.773600E-01
Stage2-vs-Stage3
2.524200E-01
Stage2-vs-Stage4
5.529200E-01
Stage3-vs-Stage4
6.964000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.830800E-01
Normal-vs-AfricanAmerican
7.027600E-01
Normal-vs-Asian
4.556300E-02
Caucasian-vs-AfricanAmerican
7.236800E-01
Caucasian-vs-Asian
1.138080E-02
AfricanAmerican-vs-Asian
6.861900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.281400E-01
Normal-vs-Female
2.223000E-01
Male-vs-Female
1.544120E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.971600E-01
Normal-vs-Age(41-60Yrs)
5.873600E-01
Normal-vs-Age(61-80Yrs)
3.318400E-01
Normal-vs-Age(81-100Yrs)
8.459000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.316000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.867400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.594200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.333000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.166200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.545250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.856850E-01
Normal-vs-Daily Drinker
3.254800E-01
Normal-vs-Weekly Drinker
5.944000E-01
Normal-vs-Occasional Drinker
9.189600E-01
Normal-vs-Social Drinker
2.418800E-01
Non Drinker-vs-Daily Drinker
8.600200E-01
Non Drinker-vs-Weekly Drinker
3.825200E-01
Non Drinker-vs-Occasional Drinker
3.978300E-02
Non Drinker-vs-Social Drinker
9.036200E-01
Daily Drinker-vs-Weekly Drinker
5.470200E-01
Daily Drinker-vs-Occasional Drinker
1.117850E-01
Daily Drinker-vs-Social Drinker
9.648800E-01
Weekly Drinker-vs-Occasional Drinker
4.310400E-01
Weekly Drinker-vs-Social Drinker
5.281000E-01
Occasional Drinker-vs-Social Drinker
1.148420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.136000E-01
Normal-vs-Grade 2
9.913000E-01
Normal-vs-Grade 3
9.735200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.574600E-01
Grade 1-vs-Grade 3
4.793900E-02
Grade 1-vs-Grade 4
9.136000E-01
Grade 2-vs-Grade 3
4.480000E-01
Grade 2-vs-Grade 4
9.913000E-01
Grade 3-vs-Grade 4
9.735200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.529600E-01
Normal-vs-NonDiabetic
3.776200E-01
Diabetic-vs-NonDiabetic
5.725000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.602010E-01
Normal-vs-NoPancreatitis
4.079800E-01
Pancreatitis-vs-NoPancreatitis
2.807000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.328400E-01
Normal-vs-N1
5.039800E-01
N0-vs-N1
5.114200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.533000E-01
Normal-vs-TP53-NonMutant
7.134000E-01
TP53-Mutant-vs-TP53-NonMutant
2.093800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
